Masimo to Sell Consumer Audio Business to HARMAN International
Divestiture Supports
The transaction is subject to the satisfaction or waiver of certain closing conditions, including the receipt of any required regulatory approvals.
About Masimo
Masimo (NASDAQ: MASI) is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and automation and connectivity solutions. In addition, Masimo Consumer Audio is home to eight legendary audio brands, including Bowers & Wilkins, Denon, Marantz, and
About HARMAN
HARMAN (harman.com) designs and engineers connected products and solutions for automakers, consumers, and enterprises worldwide, including connected car systems, audio and visual products, enterprise automation solutions; and services supporting the Internet of Things. With leading brands including AKG®, Harman Kardon®, Infinity®, JBL®, Lexicon®, Mark Levinson® and Revel®, HARMAN is admired by audiophiles, musicians and the entertainment venues where they perform around the world. More than 50 million automobiles on the road today are equipped with HARMAN audio and connected car systems. Our software services power billions of mobile devices and systems that are connected, integrated and secure across all platforms, from work and home to car and mobile. HARMAN has a workforce of approximately 30,000 people across the
Forward-Looking Statements – Masimo
All statements other than statements of historical facts included in this press release that address activities, events or developments that we expect, believe or anticipate will or may occur in the future are forward-looking statements including, in particular, the statements about our expectations regarding the expected timeline to closing of the transaction. These forward-looking statements are based on management’s current expectations and beliefs and are subject to uncertainties and factors, all of which are difficult to predict and many of which are beyond our control and could cause actual results to differ materially and adversely from those described in the forward-looking statements. These risks include, but are not limited to, those related to (i) the inability to obtain, or delays in obtaining, any required regulatory or other approvals for the transaction, or failure to consummate or delay in consummating the transaction for any other reasons; (ii) the risk that a condition to closing of the transaction may not be satisfied; (iii) the occurrence of any event, change or other circumstances that could give rise to the termination of the transaction; (iv) the outcome of any legal proceedings that may be instituted following announcement of the transaction; (v) potential unfavorable reactions to the transaction by customers, competitors, suppliers, employees and Company stockholders; and (vi) each party’s ability to satisfy its respective obligations in connection with the transaction; and other factors discussed in the “Risk Factors” section of our periodic reports filed with the
View source version on businesswire.com: https://www.businesswire.com/news/home/20250506528578/en/
Masimo Contacts:
Media
Phone: (949) 396-3376
Email: elamb@masimo.com
OR
masimo@longacresquare.com
Investors
Phone: (949) 297-7077
Email: ekammerman@masimo.com
HARMAN Contacts
Phone: +49 171 867 4151
Email: carole.campbell@harman.com
Phone: (203) 554-9103
Email: Darrin.shewchuk@harman.com
Source: Masimo